{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:43:45Z","timestamp":1790775825590,"version":"4.1.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,14]],"date-time":"2024-09-14T00:00:00Z","timestamp":1726272000000},"content-version":"am","delay-in-days":349,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["R21 AR080233"],"award-info":[{"award-number":["R21 AR080233"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00e9dicale","doi-asserted-by":"publisher","award":["FRM EQU202203014650"],"award-info":[{"award-number":["FRM EQU202203014650"]}],"id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017228","name":"European Genomic Institute for Diabetes","doi-asserted-by":"publisher","award":["ANR-16-RHUS-0006"],"award-info":[{"award-number":["ANR-16-RHUS-0006"]}],"id":[{"id":"10.13039\/100017228","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010663","name":"ERC","doi-asserted-by":"publisher","award":["101042759"],"award-info":[{"award-number":["101042759"]}],"id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010663","name":"ERC","doi-asserted-by":"publisher","award":["694717"],"award-info":[{"award-number":["694717"]}],"id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004431","name":"Fondation de France","doi-asserted-by":"publisher","award":["00133549\/WB-2022-45062"],"award-info":[{"award-number":["00133549\/WB-2022-45062"]}],"id":[{"id":"10.13039\/501100004431","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"ANR","doi-asserted-by":"publisher","award":["ANR-10-LABX-0046"],"award-info":[{"award-number":["ANR-10-LABX-0046"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.jhep.2023.05.012","type":"journal-article","created":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T20:56:24Z","timestamp":1684875384000},"page":"898-909","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Roux-en-Y gastric bypass induces hepatic transcriptomic signatures and plasma metabolite changes indicative of improved cholesterol homeostasis"],"prefix":"10.1016","volume":"79","author":[{"given":"Fanny","family":"Lalloyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5427-5243","authenticated-orcid":false,"given":"Denis A.","family":"Mogilenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4098-8837","authenticated-orcid":false,"given":"Ann","family":"Verrijken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0028-5988","authenticated-orcid":false,"given":"Joel T.","family":"Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonin","family":"Lamazi\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2034-800X","authenticated-orcid":false,"given":"Mostafa","family":"Kouach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5981-4995","authenticated-orcid":false,"given":"Amandine","family":"Descat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Caron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Vallez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0617-1658","authenticated-orcid":false,"given":"Bruno","family":"Derudas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4096-6363","authenticated-orcid":false,"given":"C\u00e9line","family":"Gheeraert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Baug\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ga\u00ebtan","family":"Despres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eveline","family":"Dirinck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Tailleux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0485-8923","authenticated-orcid":false,"given":"David","family":"Dombrowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Van Gaal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jer\u00f4me","family":"Eeckhoute","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Lefebvre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8551-0899","authenticated-orcid":false,"given":"Jean-Fran\u00e7ois","family":"Goossens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7527-4714","authenticated-orcid":false,"given":"Sven","family":"Francque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3784-1503","authenticated-orcid":false,"given":"Bart","family":"Staels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2023.05.012_bib1","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s41574-019-0176-8","article-title":"Obesity: global epidemiology and pathogenesis","volume":"15","author":"Bl\u00fcher","year":"2019","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.jhep.2023.05.012_bib2","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1056\/NEJMoa1600869","article-title":"Bariatric surgery versus intensive medical therapy for diabetes - 5-year outcomes","volume":"376","author":"Schauer","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhep.2023.05.012_bib3","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/jama.2011.1914","article-title":"Bariatric surgery and long-term cardiovascular events","volume":"307","author":"Sj\u00f6str\u00f6m","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.jhep.2023.05.012_bib4","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3389\/fcvm.2019.00094","article-title":"Effects of bariatric surgery on cardiovascular disease: a concise update of recent advances","volume":"6","author":"Kuno","year":"2019","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jhep.2023.05.012_bib5","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1053\/j.gastro.2020.06.006","article-title":"Bariatric surgery provides long-term resolution of nonalcoholic steatohepatitis and regression of fibrosis","volume":"159","author":"Lassailly","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2023.05.012_bib6","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1056\/NEJMoa066603","article-title":"Long-term mortality after gastric bypass surgery","volume":"357","author":"Adams","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhep.2023.05.012_bib7","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1007\/s11695-014-1484-7","article-title":"Roux-en-Y gastric bypass decreases pro-inflammatory and thrombotic biomarkers in individuals with extreme obesity","volume":"25","author":"Netto","year":"2015","journal-title":"Obes Surg"},{"key":"10.1016\/j.jhep.2023.05.012_bib8","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jhep.2015.02.019","article-title":"PPAR\u03b1 gene expression correlates with severity and histological treatment response in patients with non-alcoholic steatohepatitis","volume":"63","author":"Francque","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.05.012_bib9","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1038\/ijo.2016.46","article-title":"Influence of Roux-en-Y gastric bypass on plasma bile acid profiles: a comparative study between rats, pigs and humans","volume":"40","author":"Spinelli","year":"2016","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.jhep.2023.05.012_bib10","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1210\/jc.2017-01397","article-title":"Bile acid alterations are associated with insulin resistance, but not with NASH, in obese subjects","volume":"102","author":"Legry","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jhep.2023.05.012_bib11","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/brain\/awv384","article-title":"CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington\u2019s disease","volume":"139","author":"Boussicault","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.jhep.2023.05.012_bib12","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1186\/1471-2105-9-559","article-title":"WGCNA: an R package for weighted correlation network analysis","volume":"9","author":"Langfelder","year":"2008","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.jhep.2023.05.012_bib13","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/s42255-019-0076-1","article-title":"Transcriptional network analysis implicates altered hepatic immune function in NASH development and resolution","volume":"1","author":"Haas","year":"2019","journal-title":"Nat Metab"},{"key":"10.1016\/j.jhep.2023.05.012_bib14","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.05.012_bib15","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev.biochem.72.121801.161712","article-title":"The enzymes, regulation, and genetics of bile acid synthesis","volume":"72","author":"Russell","year":"2003","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.jhep.2023.05.012_bib16","first-page":"11","article-title":"Common and rare gene variants affecting plasma LDL cholesterol","volume":"29","author":"Burnett","year":"2008","journal-title":"Clin Biochem Rev"},{"key":"10.1016\/j.jhep.2023.05.012_bib17","doi-asserted-by":"crossref","first-page":"12027","DOI":"10.1073\/pnas.1534923100","article-title":"Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes","volume":"100","author":"Horton","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2023.05.012_bib18","first-page":"123","article-title":"Serum concentrations of 7alpha-hydroxy-4-cholesten-3-one reflect bile acid synthesis in humans","volume":"24","author":"Sauter","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.05.012_bib19","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1194\/jlr.D200043-JLR200","article-title":"Monitoring hepatic cholesterol 7\u03b1-hydroxylase activity by assay of the stable bile acid intermediate 7\u03b1-hydroxy-4-cholesten-3-one in peripheral blood","volume":"44","author":"G\u00e4lman","year":"2003","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.jhep.2023.05.012_bib20","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/oxfordjournals.aje.a115479","article-title":"Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population","volume":"131","author":"Miettinen","year":"1990","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jhep.2023.05.012_bib21","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.numecd.2011.05.005","article-title":"The role of serum non-cholesterol sterols as surrogate markers of absolute cholesterol synthesis and absorption","volume":"21","author":"Miettinen","year":"2011","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.jhep.2023.05.012_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2021.101109","article-title":"Hepatic cholesterol transport and its role in non-alcoholic fatty liver disease and atherosclerosis","volume":"83","author":"Li","year":"2021","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.jhep.2023.05.012_bib23","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1053\/j.gastro.2015.04.014","article-title":"Bariatric surgery reduces features of nonalcoholic steatohepatitis in morbidly obese patients","volume":"149","author":"Lassailly","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2023.05.012_bib24","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.metabol.2009.10.004","article-title":"Cholesterol absorption decreases after Roux-en-Y gastric bypass but not after gastric banding","volume":"59","author":"Pihlajam\u00e4ki","year":"2010","journal-title":"Metabolism"},{"key":"10.1016\/j.jhep.2023.05.012_bib25","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jacl.2008.01.004","article-title":"Balancing cholesterol synthesis and absorption in the gastrointestinal tract","volume":"2","author":"Cohen","year":"2008","journal-title":"J\u00a0Clin Lipidol"},{"key":"10.1016\/j.jhep.2023.05.012_bib26","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3390\/nu11010124","article-title":"Non-cholesterol sterol concentrations as biomarkers for cholesterol absorption and synthesis in different metabolic disorders: a systematic review","volume":"11","author":"Mashnafi","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.jhep.2023.05.012_bib27","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1210\/en.2018-00098","article-title":"Intestine-specific overexpression of LDLR enhances cholesterol excretion and induces metabolic changes in male mice","volume":"160","author":"Meoli","year":"2019","journal-title":"Endocrinology"},{"key":"10.1016\/j.jhep.2023.05.012_bib28","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.diabet.2020.01.003","article-title":"Roux-en-Y gastric bypass, but not sleeve gastrectomy, decreases plasma PCSK9 levels in morbidly obese patients","volume":"46","author":"Blanchard","year":"2020","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.jhep.2023.05.012_bib29","doi-asserted-by":"crossref","first-page":"25517","DOI":"10.1074\/jbc.M302588200","article-title":"NPC1 and NPC2 regulate cellular cholesterol homeostasis through generation of low density lipoprotein cholesterol-derived oxysterols","volume":"278","author":"Frolov","year":"2003","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jhep.2023.05.012_bib30","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s11695-015-1834-0","article-title":"FGF 19 and bile acids increase following roux-en-Y gastric bypass but not after medical management in patients with type 2 diabetes","volume":"26","author":"Sachdev","year":"2016","journal-title":"Obes Surg"},{"key":"10.1016\/j.jhep.2023.05.012_bib31","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.2337\/dc12-2255","article-title":"A\u00a0role for fibroblast growth factor 19 and bile acids in diabetes remission after roux-en-Y gastric bypass","volume":"36","author":"Gerhard","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jhep.2023.05.012_bib32","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1210\/en.2011-2145","article-title":"The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control","volume":"153","author":"Pournaras","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.jhep.2023.05.012_bib33","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nm.4357","article-title":"Cold-induced conversion of cholesterol to bile acids in mice shapes the gut microbiome and promotes adaptive thermogenesis","volume":"23","author":"Worthmann","year":"2017","journal-title":"Nat Med"},{"key":"10.1016\/j.jhep.2023.05.012_bib34","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.livres.2019.05.001","article-title":"The acidic pathway of bile acid synthesis: not just an alternative pathway","volume":"3","author":"Pandak","year":"2019","journal-title":"Liver Res"},{"key":"10.1016\/j.jhep.2023.05.012_bib35","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.taap.2013.01.022","article-title":"Decreased hepatotoxic bile acid composition and altered synthesis in progressive human nonalcoholic fatty liver disease","volume":"268","author":"Lake","year":"2013","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.jhep.2023.05.012_bib36","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/cen.12496","article-title":"Calorie restriction and Roux-en-Y gastric bypass have opposing effects on circulating FGF21 in morbidly obese subjects","volume":"81","author":"Lips","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jhep.2023.05.012_bib37","article-title":"Changes in fasting bile acid profiles after Roux-en-Y gastric bypass and sleeve gastrectomy","volume":"100","author":"Zhang","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jhep.2023.05.012_bib38","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13038","article-title":"Effect of bariatric surgery on circulating FGF-19: a systematic review and meta-analysis","volume":"21","author":"Ryan","year":"2020","journal-title":"Obes Rev"},{"key":"10.1016\/j.jhep.2023.05.012_bib39","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1007\/s10620-015-3776-8","article-title":"Altered bile acid metabolome in patients with nonalcoholic steatohepatitis","volume":"60","author":"Ferslew","year":"2015","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2023.05.012_bib40","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/hep.29359","article-title":"The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids","volume":"67","author":"Puri","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.05.012_bib41","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1056\/NEJM199810223391707","article-title":"Molecular pathogenesis of cholestasis","volume":"339","author":"Trauner","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhep.2023.05.012_bib42","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/liv.13201","article-title":"Serum\u00a0bile acids as marker for acute decompensation and acute-on-chronic liver failure in patients with non-cholestatic cirrhosis","volume":"37","author":"Horvatits","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2023.05.012_bib43","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13613-017-0272-7","article-title":"Circulating bile acids predict outcome in critically ill patients","volume":"7","author":"Horvatits","year":"2017","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.jhep.2023.05.012_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151829","article-title":"Bile acids and dysbiosis in non-alcoholic fatty liver disease","volume":"11","author":"Mouzaki","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2023.05.012_bib45","article-title":"NASH-related increases in plasma bile acid levels depend on insulin resistance","volume":"3","author":"Grzych","year":"2021","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhep.2023.05.012_bib46","doi-asserted-by":"crossref","first-page":"G440","DOI":"10.1152\/ajpgi.00322.2009","article-title":"The hepatic response to FGF19 is impaired in patients with nonalcoholic fatty liver disease and insulin resistance","volume":"298","author":"Schreuder","year":"2010","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhep.2023.05.012_bib47","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.3389\/fphar.2020.01084","article-title":"Mechanism of hydrophobic bile acid-induced hepatocyte injury and drug discovery","volume":"11","author":"Wei","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jhep.2023.05.012_bib48","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1001\/archinte.159.22.2647","article-title":"The continuing importance of bile acids in liver and intestinal disease","volume":"159","author":"Hofmann","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jhep.2023.05.012_bib49","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.3748\/wjg.15.1677","article-title":"Bile-acid-induced cell injury and protection","volume":"15","author":"Perez","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2023.05.012_bib50","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1038\/nm1138","article-title":"Prevention of cholesterol gallstone disease by FXR agonists in a mouse model","volume":"10","author":"Moschetta","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.jhep.2023.05.012_bib51","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.bbadis.2015.05.015","article-title":"Recent insights on the role of cholesterol in non-alcoholic fatty liver disease","volume":"1852","author":"Arguello","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jhep.2023.05.012_bib52","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.cmet.2012.04.004","article-title":"Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease","volume":"15","author":"Min","year":"2012","journal-title":"Cell Metab"},{"key":"10.1016\/j.jhep.2023.05.012_bib53","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/hep.22363","article-title":"Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis","volume":"48","author":"Wouters","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2023.05.012_bib54","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1053\/j.gastro.2011.06.040","article-title":"Hepatic free cholesterol accumulates in obese, diabetic mice and causes nonalcoholic steatohepatitis","volume":"141","author":"Van Rooyen","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2023.05.012_bib55","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jhep.2013.02.024","article-title":"Pharmacological cholesterol lowering reverses fibrotic NASH in obese, diabetic mice with metabolic syndrome","volume":"59","author":"Van Rooyen","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.05.012_bib56","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.jhep.2009.05.017","article-title":"Long-term combination therapy of ezetimibe and acarbose for non-alcoholic fatty liver disease","volume":"51","author":"Nozaki","year":"2009","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.05.012_bib57","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1136\/gutjnl-2016-312975","article-title":"Fibroblast growth factor 15\/19 (FGF15\/19) protects from diet-induced hepatic steatosis: development of an FGF19-based chimeric molecule to promote fatty liver regeneration","volume":"66","author":"Alvarez-Sola","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2023.05.012_bib58","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1007\/s12325-019-00898-6","article-title":"Pharmacological treatment for non-alcoholic fatty liver disease","volume":"36","author":"Francque","year":"2019","journal-title":"Adv Ther"},{"key":"10.1016\/j.jhep.2023.05.012_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.601349","article-title":"FGF19 and FGF21 for the treatment of NASH-two sides of the same coin? Differential and overlapping effects of FGF19 and FGF21 from mice to human","volume":"11","author":"Henriksson","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jhep.2023.05.012_bib60","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.jhep.2022.04.002","article-title":"Breakthroughs in therapies for NASH and remaining challenges","volume":"76","author":"Ratziu","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.05.012_bib61","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jhep.2010.05.037","article-title":"Cholesterol synthesis is increased and absorption decreased in non-alcoholic fatty liver disease independent of obesity","volume":"54","author":"Simonen","year":"2011","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2023.05.012_bib62","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.3390\/nu13113873","article-title":"A\u00a0comparison of total food intake at a personalised buffet in people with obesity, before and 24 Months after roux-en-Y-gastric bypass surgery","volume":"13","author":"Kapoor","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.jhep.2023.05.012_bib63","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1093\/ajcn\/30.7.1135","article-title":"Effects of acute caloric restriction on cholesterol metabolism in man","volume":"30","author":"Kudchodkar","year":"1977","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jhep.2023.05.012_bib64","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/joim.12599","article-title":"Acute caloric restriction counteracts hepatic bile acid and cholesterol deficiency in morbid obesity","volume":"281","author":"Straniero","year":"2017","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.jhep.2023.05.012_bib65","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.numecd.2008.04.005","article-title":"Bariatric surgery in obesity: changes of glucose and lipid metabolism correlate with changes of fat mass","volume":"19","author":"Frige\u2019","year":"2009","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.jhep.2023.05.012_bib66","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1016\/j.clnu.2018.12.028","article-title":"Fecal bile acid profile after Roux-en-Y gastric bypass and its association with the remission of type 2 diabetes in obese women: a preliminary study","volume":"38","author":"Siqueira Cardinelli","year":"2019","journal-title":"Clin Nutr"},{"key":"10.1016\/j.jhep.2023.05.012_bib67","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41522-020-0122-5","article-title":"Temporospatial shifts in the human gut microbiome and metabolome after gastric bypass surgery","volume":"6","author":"Ilhan","year":"2020","journal-title":"NPJ Biofilms Microbiomes"},{"key":"10.1016\/j.jhep.2023.05.012_bib68","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3390\/metabo11110733","article-title":"Gut microbiota metabolism of bile acids could contribute to the bariatric surgery improvements in extreme obesity","volume":"11","author":"Oca\u00f1a-Wilhelmi","year":"2021","journal-title":"Metabolites"},{"key":"10.1016\/j.jhep.2023.05.012_bib69","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1136\/gutjnl-2018-316103","article-title":"Major microbiota dysbiosis in severe obesity: fate after bariatric surgery","volume":"68","author":"Aron-Wisnewsky","year":"2019","journal-title":"Gut"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827823003410?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827823003410?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:56:46Z","timestamp":1777510606000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827823003410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":69,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S0168827823003410"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2023.05.012","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Roux-en-Y gastric bypass induces hepatic transcriptomic signatures and plasma metabolite changes indicative of improved cholesterol homeostasis","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2023.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}